Descriptor English: Halofenate
Descriptor Spanish: Halofenato
Descriptor halofenato
Scope note: Agente antihiperlipoproteinémico y uricosúrico.
Descriptor Portuguese: Halofenato
Descriptor French: Halofénate
Entry term(s): MK 185
Tree number(s): D02.
RDF Unique Identifier:
Scope note: An antihyperlipoproteinemic agent and uricosuric agent.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Hypolipidemic Agents
Uricosuric Agents
Registry Number: K9TZK4MNO6
CAS Type 1 Name: Benzeneacetic acid, 4-chloro-alpha-(3-(trifluoromethyl)phenoxy)-, 2-(acetylamino)ethyl ester
Previous Indexing: Anticholesteremic Agents (1966-1972)
Antilipemic Agents (1966-1972)
Glycolates (1966-1972)
Public MeSH Note: 91; was see under GLYCOLATES 1973-90
History Note: 91(73); was see under GLYCOLATES 1973-90
DeCS ID: 6371
Unique ID: D006218
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1999/01/01
Revision Date: 2013/07/08
Halofenate - Preferred
Concept UI M0009769
Scope note An antihyperlipoproteinemic agent and uricosuric agent.
Preferred term Halofenate
MK-185 - Narrower
Concept UI M0351749
Preferred term MK-185
Entry term(s) MK 185

We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey